Adeline (Pinyu) Liao is a Stanford researcher and the founder of Niora Systems, a pharmaceutical procurement platform addressing one of the most consequential failures in global health: chronic drug stockouts in low- and middle-income countries.

At Stanford, she studies Computational Biology and Economics, with a focus on antimicrobial resistance, market design, and health systems. Her work spans laboratory research, economic modelling, and field-based system design, informed by experience in academic research, global health consulting, and public scholarship, including a TEDxStanford 2024 talk. In 2025, she founded Niora Systems, securing pilot agreements with Ghana’s leading hospitals and assembling an international execution team across healthcare operations, logistics, and technology to build a scalable, institution-grade solution for pharmaceutical reliability.

Born in rural Taiwan, Adeline’s trajectory has consistently placed her at the far edge of academic, technical, and creative execution from an unusually early age. Prior to Stanford, she was selected for the Research Science Institute (RSI), the world’s most selective high school research program, won Second Place at the Intel International Science and Engineering Fair (ISEF), and was named a Regeneron Science Talent Search Scholar and Coca-Cola Scholar. She was also recognized by The 74 Million as one of the 16 Most Accomplished Individuals Under 16. Alongside her biotech research, including contributions to two publications in Cell, she founded Lavender + Lab Coats, a science and medicine storytelling platform that reached over 75,000 monthly readers across 148 countries. Her original documentary, The Quest to Stop Antibiotic Resistance, was screened by the World Health Organization and recognized at six international film festivals.

Adeline’s work blends rigorous science with institutional and market design. Rather than treating drug access as a logistics problem alone, she focuses on rewriting the economic and operational incentives that determine whether medicines reliably reach patients. Through Niora, she is building the foundations of a multinational platform designed to stabilize pharmaceutical access across the Global South—transforming fragmented procurement systems into durable, accountable infrastructure.